160 related articles for article (PubMed ID: 9063487)
1. [Antitumor effect and mechanism of a novel multifunctional nucleoside, 3'-ethynylnucleoside, on human cancers].
Tanaka M; Tabata S; Matsuda A; Fukushima M; Eshima K; Sasaki T
Gan To Kagaku Ryoho; 1997 Feb; 24(4):476-82. PubMed ID: 9063487
[TBL] [Abstract][Full Text] [Related]
2. Nucleosides and nucleotides. 158. 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)-cytosine, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)uracil, and their nucleobase analogues as new potential multifunctional antitumor nucleosides with a broad spectrum of activity.
Hattori H; Tanaka M; Fukushima M; Sasaki T; Matsuda A
J Med Chem; 1996 Dec; 39(25):5005-11. PubMed ID: 8960561
[TBL] [Abstract][Full Text] [Related]
3. Antitumor mechanisms and metabolism of the novel antitumor nucleoside analogues, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine and 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)uracil.
Takatori S; Kanda H; Takenaka K; Wataya Y; Matsuda A; Fukushima M; Shimamoto Y; Tanaka M; Sasaki T
Cancer Chemother Pharmacol; 1999; 44(2):97-104. PubMed ID: 10412942
[TBL] [Abstract][Full Text] [Related]
4. A crucial role of uridine/cytidine kinase 2 in antitumor activity of 3'-ethynyl nucleosides.
Murata D; Endo Y; Obata T; Sakamoto K; Syouji Y; Kadohira M; Matsuda A; Sasaki T
Drug Metab Dispos; 2004 Oct; 32(10):1178-82. PubMed ID: 15280220
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic mechanisms of new antitumor nucleoside analogues, 3'-ethynylcytidine (ECyd) and 3'-ethynyluridine (EUrd).
Kanda H; Takatori S; Matsuda A; Sasaki T; Tanaka M; Fukushima M; Wataya Y
Nucleic Acids Symp Ser; 1997; (37):137-8. PubMed ID: 9586037
[TBL] [Abstract][Full Text] [Related]
6. Nucleosides and nucleotides. 175. Structural requirements of the sugar moiety for the antitumor activities of new nucleoside antimetabolites, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine and -uracil1.
Hattori H; Nozawa E; Iino T; Yoshimura Y; Shuto S; Shimamoto Y; Nomura M; Fukushima M; Tanaka M; Sasaki T; Matsuda A
J Med Chem; 1998 Jul; 41(15):2892-902. PubMed ID: 9667977
[TBL] [Abstract][Full Text] [Related]
7. Antitumor effect of a novel multifunctional antitumor nucleoside, 3'-ethynylcytidine, on human cancers.
Tabata S; Tanaka M; Matsuda A; Fukushima M; Sasaki T
Oncol Rep; 1996 Nov; 3(6):1029-34. PubMed ID: 21594501
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of nucleobase-modified analogs of the anticancer compounds 3'-C-ethynyluridine (EUrd) and 3'-C-ethynylcytidine (ECyd).
Hrdlicka PJ; Jepsen JS; Nielsen C; Wengel J
Bioorg Med Chem; 2005 Feb; 13(4):1249-60. PubMed ID: 15670934
[TBL] [Abstract][Full Text] [Related]
9. PK-PD modeling of 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine and the enhanced antitumor effect of its phospholipid derivatives in long-circulating liposomes.
Takada A; Kamiya H; Shuto S; Matsuda A; Harashima H
Int J Pharm; 2009 Jul; 377(1-2):52-9. PubMed ID: 19426792
[TBL] [Abstract][Full Text] [Related]
10. 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106)1: antitumor effect and mechanism of action.
Azuma A; Matsuda A; Sasaki T; Fukushima M
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):609-19. PubMed ID: 11563078
[TBL] [Abstract][Full Text] [Related]
11. 1-(3-C-Ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106), a novel potent inhibitor of RNA polymerase, potentiates the cytotoxicity of CDDP in human cancer cells both in vitro and in vivo.
Kazuno H; Fujioka A; Fukushima M; Wataya Y; Matsuda A; Sasaki T
Int J Oncol; 2009 May; 34(5):1373-80. PubMed ID: 19360349
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of action of a new antitumor ribonucleoside, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106), differs from that of 5-fluorouracil.
Kazuno H; Shimamoto Y; Tsujimoto H; Fukushima M; Matsuda A; Sasaki T
Oncol Rep; 2007 Jun; 17(6):1453-60. PubMed ID: 17487404
[TBL] [Abstract][Full Text] [Related]
13. Anticancer mechanisms of 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl) cytosine (ECyd, TAS-106).
Naito T; Yokogawa T; Kim HS; Futagami M; Wataya Y; Matsuda A; Fukushima M; Kitade Y; Sasaki T
Nucleic Acids Res Suppl; 2002; (2):241-2. PubMed ID: 12903195
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory mechanisms of 1-(3-C-ethynyl-beta-D-ribopentofuranosyl)uracil (EUrd) on RNA synthesis.
Yokogawa T; Naito T; Kanda H; Takatori S; Takenaka K; Sasaki T; Matsuda A; Fukushima M; Kim HS; Wataya Y
Nucleosides Nucleotides Nucleic Acids; 2005; 24(3):227-32. PubMed ID: 15892261
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor mechanisms of 3'-ethynyluridine and 3'-ethynylcytidine as RNA synthesis inhibitors: development and characterization of 3'-ethynyluridine-resistant cells.
Tabata S; Tanaka M; Endo Y; Obata T; Matsuda A; Sasaki T
Cancer Lett; 1997 Jun; 116(2):225-31. PubMed ID: 9215867
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of branched and conformationally restricted analogs of the anticancer compounds 3'-C-ethynyluridine (EUrd) and 3'-C-ethynylcytidine (ECyd).
Hrdlicka PJ; Andersen NK; Jepsen JS; Hansen FG; Haselmann KF; Nielsen C; Wengel J
Bioorg Med Chem; 2005 Apr; 13(7):2597-621. PubMed ID: 15755661
[TBL] [Abstract][Full Text] [Related]
17. Anticancer molecular mechanism of 3'-ethynylcytidine (ECyd).
Wataya Y; Futagami M; Naito T; Uchikubo Y; Yokogawa T; Takenaka K; Kim HS; Matsuda A; Fukushima M; Kitade Y
Nucleic Acids Res Suppl; 2001; (1):233-4. PubMed ID: 12836350
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity and mechanism of action of the novel marine natural products mycalamide-A and -B and onnamide.
Burres NS; Clement JJ
Cancer Res; 1989 Jun; 49(11):2935-40. PubMed ID: 2720652
[TBL] [Abstract][Full Text] [Related]
19. A new antitumor nucleoside, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd), is a potent inhibitor of RNA synthesis.
Matsuda A; Fukushima M; Wataya Y; Sasaki T
Nucleosides Nucleotides; 1999; 18(4-5):811-4. PubMed ID: 10432683
[TBL] [Abstract][Full Text] [Related]
20. Cellular and biochemical mechanisms of the resistance of human cancer cells to a new anticancer ribo-nucleoside, TAS-106.
Shimamoto Y; Kazuno H; Murakami Y; Azuma A; Koizumi K; Matsuda A; Sasaki T; Fukushima M
Jpn J Cancer Res; 2002 Apr; 93(4):445-52. PubMed ID: 11985795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
